Computer Technology News
PRESS RELEASE ARCHIVES FROM SEND2PRESS® NEWSWIRE
NOTICE: THIS IS ARCHIVAL CONTENT AND LIKELY OUT OF DATE.
Edited for Send2Press by Carly Zander
InSciTek Successfully Closes $4.0 Million Series C Capital Round for the Allworx 10x Product
Investment reaches $10.1 million - Company beating the market odds
ROCHESTER, NY - February 19, 2004 /Send2Press Newswire/ -- InSciTek Microsystems, Inc. is beating
the market odds in both raising capital and market penetration - excellent for a high-tech
startup company located in Upstate New York. InSciTek Microsystems has delivered to the market
an innovative IT and Telephony product for small to mid-sized businesses known as the Allworx?
10x, while simultaneously raising sizeable capital investments.
"It's exciting to know we are beating the market trends. We have spent that last year focusing on
four key areas - technology development, fund raising, customer satisfaction and distribution.
Our market penetration is based on designing leading-edge convergence technology solutions that
deliver tangible, bottom-line business improvements for our customers. This funding will allow
us to extend our reach and penetration," states George Daddis, Jr., President and Chief Executive
According to industry experts, venture capital for 2003 began to settle out to a comfortable,
sustainable level. For full year 2003, investments totaled $18.2 billion across 2,715 companies,
as reported by PricewaterhouseCoopers. This represents $6.7 million raised per company, on
With a total of $10.1 million raised, InSciTek beats the average by 33%. At the same time, the
telecommunication sector is beginning to show signs of growth with the availability of new
technologies such as Voice Over Internet Protocol (VoIP).
"Our timing couldn't be better to raise these funds. Of course, true proof of our performance is
in the market place. The market has responded in the same manner as our investment partners.
We've established a strong base of small business owners, who are realizing immediate benefits in
lower initial investment costs, improved customer responsiveness, reduced reoccurring expenses
and increased employee productivity due to the Allworx 10x. The Allworx 10x is a single-unit
device that integrates phone, PC network, messaging software and group collaboration capabilities
necessary for businesses to succeed today. Many of these convergence features are not typically
available to the small business", states George Daddis.
The largest investor in Series C, Performance Technologies, Inc. is contributing up to $3.0
Million, followed by Cephas Capital Partners LP and individual private investors offering up to
"At Performance Technologies, we have strategically evolved our product portfolio to incorporate
the packet-based Internet Protocol, or IP/Ethernet, as the core technology thread," said John M.
Slusser, Chairman and Chief Strategic Officer of Performance Technologies. "The Allworx 10x
represents a leading-edge application of the future of packet-based systems. Because of this
focus and vision, we feel our investment in and relationship with InSciTek will be highly
"As one of the original investors, we continue to support InSciTek because they consistently meet
our expectations in both technology performance and customer acceptance," said Jeffery Holmes,
Managing Director of Cephas Capital. "Also, the senior management team ensures a consistent focus
on meeting targets. Yet, they stay flexible and creative in their approach to the business."
InSciTek believes that small businesses today should have access to the same advanced information
and communication technologies as big enterprises. The Allworx 10x provides businesses with all
the mission-critical communications support they need in a single system. It combines PBX phone
functionality with PC network services, secured Internet access, remote office, group
collaboration tools and messaging software such as email, voicemail, unified messaging, follow-me
calling, and group calendaring. For more information, visit www.allworx.com or call 1-866-ALLWORX
Allworx is a division of InSciTek Microsystems, Inc., which was founded in 1998. InSciTek is a
multi-million dollar consulting company. Its experienced engineers apply their hardware and
software expertise to help other businesses develop high performance, cost effective digital
products, specializing in imaging, systems monitoring and communications applications. The
company is located in Fairport, NY. For more information, visit the company's web site at
www.InSciTek.com or call 585.421.3850
About Performance Technologies
Performance Technologies (Nasdaq NM: PTIX) is a leading developer of unified embedded computing
products and system-level solutions for the communications, military and commercial markets.
Serving the industry for over 20 years, our packet-based products provide our customers the
ability to supply highly available and fully-managed systems with time-to-market, performance and
Performance Technologies is headquartered in Rochester, New York. Additional operational and
engineering facilities are located in San Diego and San Luis Obispo, California, Norwood,
Massachusetts and Ottawa, Canada. For more information, visit www.pt.com.
Cephas Capital Partners LP was formed in 1997 by Jeff Holmes and Clint Campbell along with six
regional banks to provide growth capital to small and mid-sized businesses. For more information,
call (585) 231-1528.
Previous News from Allworx / InSciTek Microsystems, Inc.
FOR INFORMATION ABOUT THE COMPANY OR ORGANIZATION(S) MENTIONED IN THE ABOVE BUSINESS NEWS ARTICLE, PLEASE CONTACT THE COMPANY DIRECTLY AND NOT THIS WEBSITE.
DISCLAIMER: the above business news article is believed accurate but not guaranteed, and is based on business news supplied by the company or organization mentioned and/or quoted in the story. The organization providing the news to Send2Press is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements and public companies should be thoroughly researched before considering material investment. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news item are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope/Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article.
USE OF THE ABOVE NEWS ARTICLE
Article is Copr. © 2004 Neotrope/Send2Press. Reproduction of this news article in any form requires written authorization. You may freely link to this article. For more information on using this article in print or on your website, please visit: